Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Understanding how acne develops in different diseases could lead to new treatments.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Most patients with cicatricial alopecias face significant psychological and social challenges due to their hair loss.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

The conference concluded with plans for joint research into children's skin conditions and emphasized the importance of collaboration and patient-focused research.

Trichotillomania involves hair pulling and can be treated with therapy and medication.

The review suggests seeing a dermatologist for scarring hair loss and using treatments like minoxidil or finasteride for common male and female pattern hair loss.

Common skin conditions can greatly affect a person's mental health and social life.

Lack of certain nutrients may contribute to hair loss and proper diet or supplements could improve it.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

People with trichotillomania or skin picking disorder generally sleep worse than those without these conditions.

New research suggests treating hair loss should focus on common inflammation rather than individual molecules.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

COVID-19 reinfection may trigger alopecia areata.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.